ClinVar Miner

Submissions for variant NM_016169.4(SUFU):c.1365+1G>A

dbSNP: rs2063794106
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001346789 SCV001541015 likely pathogenic Gorlin syndrome; Medulloblastoma 2021-10-27 criteria provided, single submitter clinical testing Disruption of this splice site has been observed in individuals with clinical features of Gorlin syndrome (PMID: 29356994; Invitae). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that disruption of this splice site results in skipping of exon 11, but is expected to preserve the integrity of the reading-frame (PMID: 29356994). ClinVar contains an entry for this variant (Variation ID: 1042780). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 11 of the SUFU gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.